Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
deals
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
5
×
startups
cancer immunotherapy
national
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer
cell therapy
clinical trials
crispr
detroit blog main
detroit top stories
eli lilly
fda
fulcrum therapeutics
gene therapy
generic drugs
immunotherapy
indiana blog main
indiana top stories
investing
ipo
medicare
migraine
novartis
raleigh-durham blog main
raleigh-durham top stories
roboticsai
What
new
5
×
biotech
bio
companies
drugs
life
medicines
research
roundup
science
startup
aiming
aims
ambys
approach
approval
arrival
bails
based
big
biogen’s
biopharmaceutical
brand
bridgebio
called
capital
car
control
convo
days
deadly
deal
debuted
debuts
develop
developing
diseases
drug
earlier
emerges
Language
unset
Current search:
biotech
×
deals
×
" san francisco top stories "
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?